type 1 diabetes

FDA Grants vTv’s Type 1 Diabetes Drug Breakthrough Therapy Designation
FDA Grants vTv’s Type 1 Diabetes Drug Breakthrough Therapy Designation
BioSpace
vTv Therapeutics
TTP399
type 1 diabetes
breakthrough therapies
FDA
Flag link:
Provention warns FDA requests could delay diabetes approval
Provention warns FDA requests could delay diabetes approval
Fierce Biotech
Provention Bio
FDA
teplizumab
type 1 diabetes
Flag link:
Provention Bio gives update on teplizumab BLA, FDA feedback
Provention Bio gives update on teplizumab BLA, FDA feedback
Seeking Alpha
Provention Bio
FDA
teplizumab
type 1 diabetes
Flag link:
Vertex begins human testing for diabetes cell therapy
Vertex begins human testing for diabetes cell therapy
BioPharma Dive
Vertex
type 1 diabetes
cell therapy
VX-880
Flag link:
The diabetes 'cure' Vertex acquired in its 2019 Semma buyout? It's headed to the clinic
The diabetes 'cure' Vertex acquired in its 2019 Semma buyout? It's headed to the clinic
Endpoints
Vertex Pharmaceuticals
Semma Therapeutics
M&A
gene therapy
VX-880
type 1 diabetes
Flag link:
Lilly amps Type 1 diabetes partnerships to reach more young people
Lilly amps Type 1 diabetes partnerships to reach more young people
Fierce Pharma
Eli Lilly
pharma marketing
type 1 diabetes
Flag link:
Novo Nordisk scraps Type 1 diabetes drug after phase 2 trial
Novo Nordisk scraps Type 1 diabetes drug after phase 2 trial
Fierce Biotech
Novo Nordisk
NN9828
Victoza
clinical trials
type 1 diabetes
Flag link:
FDA urged to increase safety warnings on common diabetes drug
FDA urged to increase safety warnings on common diabetes drug
Beckers Hospital Review
Public Citizen
diabetes
citizen petitions
SGLT2 inhibitor
type 1 diabetes
Flag link:
Preventing Type 1 diabetes by deleting a stress response gene
Preventing Type 1 diabetes by deleting a stress response gene
Fierce Biotech
type 1 diabetes
diabetes
beta cells
Flag link:
FDA blocks Lilly, Boehringer's Jardiance from coveted Type 1 diabetes nod
FDA blocks Lilly, Boehringer's Jardiance from coveted Type 1 diabetes nod
Fierce Pharma
Eli Lilly
Boehringer Ingelheim
Jardiance
type 1 diabetes
diabetes
empagliflozin
Flag link:
First-of-its-Kind Bio-Artificial Pancreas on Track for Type-I Diabetes Cure
First-of-its-Kind Bio-Artificial Pancreas on Track for Type-I Diabetes Cure
CP WIre
diabetes
type 1 diabetes
artificial pancreas
Beta-O2 Technologies
devices
Flag link:
FDA OKs Novo's Fiasp for diabetic children
FDA OKs Novo's Fiasp for diabetic children
Seeking Alpha
insulin
FDA
Novo Nordisk
Fiasp
pediatrics
diabetes
type 1 diabetes
Flag link:
Lexicon Pharma shares plummet after FDA denies appeal against drug rejection
Lexicon Pharma shares plummet after FDA denies appeal against drug rejection
Reuters
Lexicon Pharmaceuticals
FDA
type 1 diabetes
Zynquista
Flag link:
FDA Panel Votes Against Lilly's Jardiance for Type I Diabetes
FDA Panel Votes Against Lilly's Jardiance for Type I Diabetes
Zacks.com
Eli Lilly
Boehringer Ingelheim
FDA
Jardiance
type 1 diabetes
Flag link:
Sanofi shows off positive PhIII trial results for Toujeo, opening the door to a new group of diabetes patients
Sanofi shows off positive PhIII trial results for Toujeo, opening the door to a new group of diabetes patients
Endpoints
Sanofi
clinical trials
type 1 diabetes
insulin
Toujeo
Flag link:
AstraZeneca's Farxiga scores FDA nod to cut risk of hospitalization for heart failure in diabetics
AstraZeneca's Farxiga scores FDA nod to cut risk of hospitalization for heart failure in diabetics
Endpoints
AstraZeneca
Farxiga
type 1 diabetes
heart failure
Flag link:
Artificial pancreas outperforms current tech in type 1 diabetes
Artificial pancreas outperforms current tech in type 1 diabetes
Pharmaforum
type 1 diabetes
devices
NIH
artificial pancreas
Control-IQ
Flag link:
Sanofi paying Lexicon $260M to exit diabetes alliance
Sanofi paying Lexicon $260M to exit diabetes alliance
BioPharma Dive
Sanofi
Lexicon Pharmaceuticals
diabetes
type 1 diabetes
Zynquista
Flag link:
Vertex’s next act: a billion-dollar bet on a cure for type 1 diabetes
Vertex’s next act: a billion-dollar bet on a cure for type 1 diabetes
Stat
Vertex Pharmaceuticals
M&A
diabetes
type 1 diabetes
Semma Therapeutics
Flag link:
How one Boston startup rode the diabetes investment wave to raise $126M
How one Boston startup rode the diabetes investment wave to raise $126M
Bizjournals
Beta Bionics
type 1 diabetes
startups
devices
Flag link:

Pages